Published in Am Rev Respir Dis on November 01, 1979
Factors influencing the size distribution of aerosols from jet nebulisers. Thorax (1983) 2.59
Cardiovascular and hypokalaemic effects of inhaled salbutamol, fenoterol, and isoprenaline. Thorax (1989) 1.87
Influence of tracheal contraction on relaxant effects in vitro of theophylline and isoprenaline. Br J Pharmacol (1981) 1.27
Therapeutic aerosols 2--Drugs available by the inhaled route. Thorax (1984) 1.23
Inhaled prazosin in asthma. Thorax (1981) 1.03
Classification of beta-adrenoceptors in human isolated bronchus. Br J Pharmacol (1984) 1.03
Effect of aminophylline on brain tissue oxygenation in patients with chronic obstructive lung disease. Thorax (1992) 1.03
The characteristics of inhibition of histamine release from human lung fragments by sodium cromoglycate, salbutamol and chlorpromazine. Br J Pharmacol (1983) 0.97
Catecholamine transport in isolated lung parenchyma of pig. Br J Pharmacol (1982) 0.94
A comparative study of beta-adrenoceptors in human and porcine lung parenchyma strip. Br J Pharmacol (1982) 0.85
Outpatient treatment of chronic obstructive pulmonary disease--a practitioner's guide. West J Med (1985) 0.81
Failure of enhancement by labetalol of bronchopulmonary effects of histamine in guinea-pigs: independence of alpha-adrenoceptor antagonism. Br J Pharmacol (1987) 0.79
Subcutaneous adrenaline versus terbutaline in the treatment of acute severe asthma. Thorax (1988) 0.78
Effect of formoterol, a long-lasting beta 2-adrenoceptor agonist, against methacholine-induced bronchoconstriction. Br J Clin Pharmacol (1990) 0.78
Pharmacotherapy of asthma. West J Med (1985) 0.75
In vitro influence of theophylline on anti-IgE-induced release from leucocytes and whole blood in asthmatic children. Agents Actions (1981) 0.75
Management of asthma in the child aged under 6 years. Br Med J (Clin Res Ed) (1981) 0.75
Rapid method for measurement of bronchial responsiveness. Thorax (1983) 7.06
The clinical pharmacology of oral and inhaled salbutamol. Clin Pharmacol Ther (1973) 4.56
Changing prevalence of asthma in Australian children. BMJ (1994) 3.94
Isoprenaline resistance and the use of pressurised aerosols in asthma. Lancet (1968) 3.33
Obesity is a risk for asthma and wheeze but not airway hyperresponsiveness. Thorax (2001) 3.27
Comparison of cardiorespiratory effects of isoprenaline and salbutamol in patients with bronchial asthma. Br Med J (1970) 3.25
Asthma in preschool children: prevalence and risk factors. Thorax (2001) 3.10
The role of the CYP2C9-Leu359 allelic variant in the tolbutamide polymorphism. Pharmacogenetics (1996) 3.02
Frequency dependence of compliance as a test for obstruction in the small airways. J Clin Invest (1969) 2.99
Bronchial hyperresponsiveness in two populations of Australian schoolchildren. I. Relation to respiratory symptoms and diagnosed asthma. Clin Allergy (1987) 2.81
A scale for the measurement of quality of life in adults with asthma. J Clin Epidemiol (1992) 2.76
Clinical assessment of bronchodilator drugs delivered by aerosol. Thorax (1973) 2.64
Toward a definition of asthma for epidemiology. Am Rev Respir Dis (1992) 2.64
Effect of propranolol in mild hypertension. Lancet (1966) 2.57
A comparison of three different techniques for giving nebulized albuterol to asthmatic patients. Am Rev Respir Dis (1974) 2.57
Lung volumes in exacerbations of asthma. Am J Med (1966) 2.44
Consumption of oily fish and childhood asthma risk. Med J Aust (1996) 2.36
Rate of decline of lung function in subjects with asthma. Eur J Respir Dis (1987) 2.27
Prevalence of asthma in adults in Busselton, Western Australia. BMJ (1992) 2.17
SElectivity of broncholidlator action of salbutamol in asthmatic patients. Br J Dis Chest (1971) 2.15
Importance of house dust mite and Alternaria allergens in childhood asthma: an epidemiological study in two climatic regions of Australia. Clin Exp Allergy (1993) 2.10
Prevalence and severity of childhood asthma and allergic sensitisation in seven climatic regions of New South Wales. Med J Aust (1995) 2.09
Influence of the epithelium on responsiveness of guinea-pig isolated trachea to contractile and relaxant agonists. Br J Pharmacol (1986) 2.07
The metabolic fate of DL(7-3H)isoprenaline in man and dog. Biochem J (1969) 2.06
Are medication record cards useful? Med J Aust (1995) 2.04
House dust mites and skin tests in different Australian localities. Aust N Z J Med (1986) 2.00
I. Ophthalmoscopic and circulatory changes in focal retinal ischaemia. Br J Ophthalmol (1966) 1.99
The fate of ( 14 C)disodium cromoglycate in man. J Pharm Pharmacol (1972) 1.97
Clinical pharmacology of beta-receptor-blocking drugs. Clin Pharmacol Ther (1970) 1.92
An exercise challenge protocol for epidemiological studies of asthma in children: comparison with histamine challenge. Eur Respir J (1994) 1.89
Factors associated with bronchial hyperresponsiveness in Australian adults and children. Eur Respir J (1992) 1.89
A comparison of salbutamol given by pressure-packed aerosol or nebulization via IPPB in acute asthma. Br J Dis Chest (1978) 1.89
The metabolism of salbutamol in man. Xenobiotica (1973) 1.88
An evaluation of an asthma quality of life questionnaire as a measure of change in adults with asthma. J Clin Epidemiol (1993) 1.85
House dust mite allergens. A major risk factor for childhood asthma in Australia. Am J Respir Crit Care Med (1996) 1.78
In vitro responsiveness of human asthmatic bronchus to carbachol, histamine, beta-adrenoceptor agonists and theophylline. Br J Clin Pharmacol (1986) 1.73
Improvement in bronchial asthma not reflected in forced expiratory volume. Lancet (1965) 1.73
Experimental retinal branch vein occlusion. Am J Ophthalmol (1970) 1.72
Effect of inhaled preservatives on asthmatic subjects. II. Benzalkonium chloride. Am Rev Respir Dis (1990) 1.67
Atopy and bronchial reactivity in Australian and Melanesian populations. Clin Allergy (1978) 1.66
Predictive markers of asthma exacerbation during stepwise dose reduction of inhaled corticosteroids. Am J Respir Crit Care Med (2001) 1.65
Difficult asthma. Eur Respir J (1998) 1.63
Risk factors for onset and remission of atopy, wheeze, and airway hyperresponsiveness. Thorax (2002) 1.61
Veno-arterial difference in alpha 1 -antitrypsin levels. Br Med J (1972) 1.59
House dust mite allergen avoidance: a randomized controlled trial of surface chemical treatment and encasement of bedding. Clin Exp Allergy (1994) 1.57
Clinical pharmacology of beta-reccer-atefoygolocarahp lnilcc clinical pharmacology of beta-receptor-blocking drugs. Clin Pharmacol Ther (1969) 1.56
The shape of the dose-response curve to histamine in asthmatic and normal subjects. Am Rev Respir Dis (1984) 1.56
Interaction of corticosteroids and catecholamines in the treatment of asthma. Thorax (1975) 1.52
Characteristics of the inflammation in biopsies from large airways of subjects with asthma and subjects with chronic airflow limitation. Am Rev Respir Dis (1992) 1.51
The fate of nebulized salbutamol (albuterol) administered by intermittent positive pressure respiration to asthmatic patients. Am Rev Respir Dis (1973) 1.51
Markers of airway inflammation and airway hyperresponsiveness in patients with well-controlled asthma. Eur Respir J (2001) 1.50
Prevalence and nature of bronchial hyperresponsiveness in subjects with chronic obstructive pulmonary disease. Am Rev Respir Dis (1985) 1.49
Influence of thyroid dysfunction on drug pharmacokinetics. Clin Pharmacokinet (1981) 1.49
Beta-adrenergic blocking drugs. Br Med J (1971) 1.49
Inhaled drugs in the prevention of asthma. Am Rev Respir Dis (1977) 1.48
Direct exposure of carpets to sunlight can kill all mites. J Allergy Clin Immunol (1994) 1.47
Reliability of a respiratory history questionnaire and effect of mode of administration on classification of asthma in children. Chest (1992) 1.47
Pharmacokinetics of inhaled salbutamol in asthmatic patients. Br J Pharmacol (1971) 1.47
Plasma prednisolone levels in man following administration in plain and enteric-coated forms. Br J Clin Pharmacol (1977) 1.46
House dust mite increase in Wagga Wagga houses. Aust N Z J Med (1993) 1.44
Tuberculosis: medical students at risk. Med J Aust (1994) 1.43
Prevalence of bronchial hyperresponsiveness in children: the relationship between asthma and skin reactivity to allergens in two communities. Int J Epidemiol (1986) 1.43
Plasma prednisolone levels after administration of prednisolone-21-phosphate as a retention enema in colitis. Br Med J (1976) 1.42
Metabolism of isoprenaline in dog and man. Br J Pharmacol (1972) 1.38
Effect of raised intraocular pressure on the retinal and choroidal circulation. Invest Ophthalmol (1968) 1.38
Sensitivity to common allergens: relation to respiratory symptoms and bronchial hyper-responsiveness in children from three different climatic areas of Australia. Clin Exp Allergy (1991) 1.37
International comparison of the prevalence of asthma symptoms and bronchial hyperresponsiveness. Am Rev Respir Dis (1988) 1.36
Longitudinal changes in atopy during a 4-year period: relation to bronchial hyperresponsiveness and respiratory symptoms in a population sample of Australian schoolchildren. J Allergy Clin Immunol (1990) 1.34
Optimal asthma control, starting with high doses of inhaled budesonide. Eur Respir J (2000) 1.34
Pharmacological responses of human and porcine lung parenchyma, bronchus and pulmonary artery. Br J Pharmacol (1982) 1.33
Ibuprofen. A review. Practitioner (1971) 1.33
Factors affecting normal values for ventilatory lung function. Am Rev Respir Dis (1972) 1.33
Correlation between the function and structure of the lung in smokers. Am Rev Respir Dis (1979) 1.33
Pitfalls in processing home electronic spirometric data in asthma. Eur Respir J (1998) 1.30
Bronchial hyperresponsiveness in two populations of Australian schoolchildren. III. Effect of exposure to environmental allergens. Clin Allergy (1987) 1.30
An exercise challenge for epidemiological studies of childhood asthma: validity and repeatability. Eur Respir J (1995) 1.29
Presence of a heterozygous substitution and its relationship to DT-diaphorase activity. Br J Cancer (1995) 1.28
Studies of chronic (nontuberculous) lung disease in New Guinea populations. The nature of the disease. Am Rev Respir Dis (1970) 1.27
Effect of intravenous injection of salbutamol in asthma. Br J Clin Pharmacol (1975) 1.26
Chronic lung disease in the territory of Papula and New Guinea--an epidemiological study. Australas Ann Med (1967) 1.26
Bronchial hyperresponsiveness in two populations of Australian schoolchildren. II. Relative importance of associated factors. Clin Allergy (1987) 1.25
Experimental papain-induced emphysema in dogs. Am Rev Respir Dis (1970) 1.23
Nocturnal asthma: role of snoring and obstructive sleep apnea. Am Rev Respir Dis (1988) 1.23
Functional ability of patients to manage medication packaging: a survey of geriatric inpatients. Age Ageing (1994) 1.22
Rapid onset of proliferative retinopathy in young insulin-independent diabetics. Br Med J (1976) 1.19
Effect of aerosol fenoterol on the severity of bronchial hyperreactivity in patients with asthma. Thorax (1983) 1.18
Blood-levels of fluorinated hydrocarbons in asthmatic patients after inhalation of pressurised aerosols. Lancet (1971) 1.18
Effect of prednisone and beclomethasone dipropionate on airway responsiveness in asthma: a comparative study. Thorax (1988) 1.17
The prevalence of asthma in the South-Fore people of Papua New Guinea. A method for field studies of bronchial reactivity. Eur J Respir Dis (1983) 1.16
Comparative efficacy of salbutamol by pressurized aerosol and wet nebulizer in acute asthma. Br J Clin Pharmacol (1980) 1.16
Exhaled nitric oxide measurements in a population sample of young adults. Am J Respir Crit Care Med (1999) 1.15
Effect of steroids on beta-adrenoceptor-mediated relaxation of pig bronchus. Br J Pharmacol (1983) 1.15
Questionnaire items that predict asthma and other respiratory conditions in adults. Chest (1998) 1.14
Organization, expression and polymorphism of the human persyn gene. Hum Mol Genet (1998) 1.14
Measurement of plasma prednisolone in man. Br J Clin Pharmacol (1975) 1.13
Co-axial bioassay of a smooth muscle relaxant factor released from guinea-pig tracheal epithelium. Br J Pharmacol (1989) 1.13